Balasa Dinverno & Foltz’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.26M | Buy |
1,822
+135
| +8% | +$93K | 0.08% | 101 |
|
|
2022
Q2 | $997K | Sell |
1,687
-86
| -5% | -$50.8K | 0.06% | 131 |
|
|
2022
Q1 | $1.24M | Buy |
1,773
+393
| +28% | +$274K | 0.08% | 112 |
|
|
2021
Q4 | $871K | Buy |
1,380
+617
| +81% | +$389K | 0.06% | 144 |
|
|
2021
Q3 | $462K | Buy |
763
+212
| +38% | +$128K | 0.03% | 200 |
|
|
2021
Q2 | $308K | Sell |
551
-91
| -14% | -$50.9K | 0.02% | 254 |
|
|
2021
Q1 | $304K | Sell |
642
-1,011
| -61% | -$479K | 0.02% | 236 |
|
|
2020
Q4 | $799K | Sell |
1,653
-850
| -34% | -$411K | 0.07% | 125 |
|
|
2020
Q3 | $1.4M | Sell |
2,503
-18
| -0.7% | -$10.1K | 0.13% | 73 |
|
|
2020
Q2 | $1.57M | Buy |
2,521
+2,019
| +402% | +$1.26M | 0.17% | 57 |
|
|
2020
Q1 | $245K | Buy |
+502
| New | +$245K | 0.03% | 212 |
|